USPTO serial 79438643
INDIVI
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INDIVI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine F. Hoffman
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell & Ber200 East Broward Blvd, Suite 2000Ft. Lauderdale, FL 33301United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus for clinical monitoring and diagnosis, namely, medical devices for monitoring neurological functions in a patient; medical apparatus for clinical monitoring and diagnosis, namely, medical devices for measuring and monitoring digital biomarkers of cognition; medical devices for measuring and monitoring digital biomarkers of movement, balance, dexterity and vision in a patient; medical devices for measuring and monitoring neurological functions in a patient; none of the above-mentioned goods in the fields of mental disorders, disorders related to substance use, psychiatry, schizophrenia or drug addiction treatment | ACTIVE | — |
| 044 | Medical services; medical services, namely, measuring movement, balance, dexterity, cognition and vision in a patient for diagnostic purposes; medical measurement services for diagnostic purposes; medical testing and analysis services for diagnostic purposes; medical services for people with neurological illnesses; medical testing for the diagnosis and treatment of persons; medical testing services; medical testing for diagnostic or treatment purposes; telemedicine services; none of the above-mentioned services in the fields of mental disorders, disorders related to substance use, psychiatry, schizophrenia or drug addiction treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 7, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 7, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 25, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 22, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 22, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 4, 2025 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |